| Apr 7, 2025 |
Apr 7, 2025 |
Tectonic Therapeutic, Inc.
|
Director |
Sell |
16.3
|
-500,000
|
-46.60%
|
✗
|
$8.6M |
| Dec 27, 2024 |
Dec 31, 2024 |
Invivyd, Inc.
|
Director |
Sell |
22.5
|
-273,763
|
-8.20%
|
✗
|
$131.5K |
| Dec 20, 2024 |
Dec 26, 2024 |
Invivyd, Inc.
|
Director |
Sell |
22.5
|
-347,559
|
-9.42%
|
✗
|
$164.9K |
| Dec 17, 2024 |
Dec 19, 2024 |
Invivyd, Inc.
|
Director |
Sell |
22.5
|
-324,241
|
-8.08%
|
✗
|
$147.8K |
| Dec 12, 2024 |
Dec 16, 2024 |
Invivyd, Inc.
|
Director |
Sell |
22.5
|
-190,359
|
-4.53%
|
✗
|
$103.4K |
| Dec 9, 2024 |
Dec 11, 2024 |
Invivyd, Inc.
|
Director |
Sell |
20.0
|
-485,400
|
-10.35%
|
✗
|
$289.4K |
| May 29, 2024 |
May 31, 2024 |
Invivyd, Inc.
|
Director |
Sell |
22.5
|
-112,381
|
-2.34%
|
✗
|
$186.6K |
| Sep 11, 2023 |
Sep 13, 2023 |
Alector, Inc.
|
Director |
Sell |
17.5
|
-500,000
|
-4.38%
|
✗
|
$3M |
| Aug 9, 2023 |
Aug 11, 2023 |
Cyclerion Therapeutics, Inc.
|
Director |
Sell |
52.5
|
-8
|
-0.02%
|
✗
|
$27.2 |
| Aug 10, 2021 |
Aug 12, 2021 |
Invivyd, Inc.
|
Director |
Buy |
96.3
|
+500,000
|
6.23%
|
✗
|
$8.5M |
| Jun 3, 2021 |
Jun 7, 2021 |
Cyclerion Therapeutics, Inc.
|
Director |
Buy |
97.5
|
+96,153
|
14.93%
|
✗
|
$300K |
| Dec 8, 2020 |
Dec 9, 2020 |
Seer, Inc.
|
Director |
Buy |
100.0
|
+78,947
|
100.00%
|
✗
|
$1.5M |
| Jun 23, 2020 |
Jun 25, 2020 |
Alector, Inc.
|
Director |
Sell |
47.5
|
-4,377
|
-0.03%
|
✗
|
$138.1K |
| May 5, 2020 |
May 6, 2020 |
Lyra Therapeutics, Inc.
|
10% Owner |
Buy |
90.0
|
+52,826
|
2.53%
|
✗
|
$845.2K |
| Dec 17, 2019 |
Dec 18, 2019 |
Phreesia, Inc.
|
10% Owner |
Sell |
16.3
|
-357,121
|
-10.00%
|
✗
|
$8.7M |
| Apr 8, 2019 |
Apr 10, 2019 |
Cyclerion Therapeutics, Inc.
|
Director |
Buy |
100.0
|
+626,117
|
3455.39%
|
✗
|
$10M |
| Nov 20, 2017 |
Nov 20, 2017 |
X4 Pharmaceuticals, Inc
|
Director |
Buy |
100.0
|
+500,000
|
36.52%
|
✗
|
$5M |
| Jun 15, 2015 |
Jun 25, 2015 |
Pulmatrix, Inc.
|
Director |
Buy |
90.0
|
+74,036
|
2.72%
|
✗
|
$509K |
| Jun 15, 2015 |
Jun 17, 2015 |
Pulmatrix, Inc.
|
Director |
Buy |
97.5
|
+4,030,232
|
102.72%
|
✗
|
$733.5K |